FY27 revenue growth: high single-digit
Management expects high single-digit revenue growth for FY27, down from earlier double-digit aspiration, due to geopolitical uncertainty and delayed deal closures.
TATAELXSI / guidance tracker
Keep management guidance in view.
Tata Elxsi · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
EBITDA margin target: 27% exit by Q4 FY27
Management targets exiting FY27 with ~27% EBITDA margin, driven by operational efficiencies, utilization improvement, and AI adoption.
Healthcare recovery expected in Q1 FY27
Management expects healthcare vertical to recover in Q1 FY27 as delayed deals close, aiming for positive growth over Q2-Q3 combined.